Stelexis Biosciences

This early-stage study is testing a new drug called eganelisib, both by itself and combined with an existing chemotherapy drug (cytarabine), in adults whose acute myeloid leukemia (AML) or related blood disorder has returned or not responded to prior treatments. The main goals ar…